Tafamidis round 2, Tafamidis round 1, Tafamidis oblong
B3461114
Phase 1 small_molecule active
Quick answer
Tafamidis round 2, Tafamidis round 1, Tafamidis oblong for aransthyretin amyloid cardiomyopathy is a Phase 1 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- aransthyretin amyloid cardiomyopathy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active